• Skip to main content
  • Skip to footer

PeDRA

Pediatric Dermatology Research Alliance

  • DONATE
  • Pay 2023 Membership Dues
  • Join PeDRA
  • Login
MENUMENU
  • Contact Us
  • For Patients & Families
        • Patient Support
        • Patient Education
        • Community Spotlight
        • Play Eczema Counts Now!
        • Patient Advisory Committee
        • Find a Pediatric Dermatologist (from SPD)
        • Parents, advocates, and patients over the age of 18 with a direct connection or significant interest in childhood skin disease or pediatric dermatology research are encouraged to join the PeDRA network for free as Community Members.

          Apply Now!

  • Education and Events
        • Virtual Education
        • PeDRA Podcasts
        • Points of Discussion Podcast
        • Mentorship Program
        • SPD/PeDRA Journal Club
        • 2022 PeDRA Annual Conference
        • Dash for Discovery Fun Run/Walk
        • Early Investigator Support
        • Play Eczema Counts Now!
        • Events Calendar
        • Save the Date! The 2023 PeDRA Annual Conference will be held November 9-11, 2023 at the Westin Buckhead Atlanta in Atlanta, GA.

           

          Listen to PeDRA’s newest podcast series, Industry 101!

  • Research
        • Grants and Fellowships
        • Resources for Researchers
        • Survey Application
        • Study Application
        • Research Areas
        • Publications
        • Now accepting applications for the Emerging Investigator Research Grants Program and Research Fellowships Program.

  • About
        • Mission & Vision
        • Leadership & Staff
        • Annual Reports & Financials
        • News Archive
        • Our Supporters
        • Our Membership
        • Our Committees
        • Getting to Know You
        • 2022 marked PeDRA’s 10th year of pursuing the vision of changing lives and healing children with skin disease through collaboration and discovery. Visit our 10th Anniversary Page to learn more about the origin of PeDRA and the many accomplishments during the first ten years!

  • Member Login

Posts

Webinar: Reviewing and Publishing – Making an Impact in Pediatric Dermatology

May 2, 2022 By Jenn Dawson

Co-editors of Pediatric Dermatology, Lionel Bercovitch, MD, and Andrea Zaenglein, MD, and chair of PeDRA’s Outcomes Committee, Carrie Coughlin, MD, MPHS, offer guidance to reviewers on how to evaluate a manuscript and advice to authors on preparing a strong manuscript for submission. These skill-sets are not only important for career success, but they help make a positive impact in the field of pediatric dermatology.


Presented in partnership with the SPD Junior Faculty and Fellows Committee.

Reviewing and Publishing – Making an Impact in Pediatric Dermatology
Recorded Live – Wednesday, June 8, 2022, at 5:30 PM PT / 8:30 PM ET

watch now

Speakers

Andrea Zaenglein, MD

Speaker

Professor of Dermatology and Pediatric Dermatology at Penn State Health

Co-Editor of Pediatric Dermatology

    Lionel Bercovitch, MD

    Speaker

    Director, Pediatric Dermatology, Professor of Dermatology at Brown University

    Co-Editor of Pediatric Dermatology

      Carrie C. Coughlin, MD, MPHS

      Speaker

      Assistant Professor, Dermatology and Pediatrics, Director – Section of Pediatric Dermatology, Director – Pediatric Dermatology Fellowship at Washington University School of Medicine

      Chair, PeDRA Outcomes Committee

        Filed Under: Education

        Three PeDRA Members Receive 2020 Research Awards from the Dermatology Foundation

        March 24, 2020 By Jenn Dawson

        March 24, 2020 – The pediatric dermatology community is proud to recognize three PeDRA members as recipients of 2020 Research Awards from the Dermatology Foundation.  Lisa Arkin, MD of the University of Wisconsin received a Pediatric Dermatology Career Development Award for a project titled Towards a Precision-based Treatment for Facial Vascular Stains, Leo Shmuylovich, MD, PhD of Washington University received a Dermatologist Investigator Research Fellowship to study Laser Stimulated Thermal Imaging of Nonmelanoma Skin Cancer, andJoy Wan, MD, MSCE of the University of Pennsylvania received a Career Development Award for a project titled Neurocognitive Functioning of Children with Atopic Dermatitis. 

        Together with Elena Hawryluk, MD, PhD (Pediatric Dermatology Career Development Award, year 3) and Jeff Yu, MD (Pediatric Dermatology Career Development Award, year 2), this brings the total of active Dermatology Foundation-funded PeDRA members to five, and impacts projects spanning three of PeDRA’s five working groups. 

        Visit the Dermatology Foundation website for information on all Research Awards granted in 2020 and to learn more about future funding opportunities.  To learn about research funding opportunities from PeDRA, visit the Grants & Awards Page.  

        Filed Under: News

        Webinar: Overview of the PeDRA Research Toolkit

        January 28, 2020 By Jenn Dawson

        This presentation includes an overview of the collaborative research process, an overview of the support that PeDRA provides at each stage, and links to external resources intended to help PeDRA Studies get off the ground and succeed.

        full toolkit here

        Audio Only Below

        Filed Under: Archive, Education, Webinars

        AAD – VMX

        January 1, 2020 By Jenn Dawson

        AAD is hosting a virtual meeting experience June 12 – 14, 2020.

        Learn more

        Filed Under: Events Archive

        PeDRA Invests $260K Through Four Grants Programs

        January 24, 2023 By Caitlin Haskell

        January 24, 2023 – In collaboration with its partner organizations, PeDRA is thrilled to continue its investment in pediatric dermatology research and commit to $260,000 through four competitive grants programs.

        Five investigators have received funding through the 2022 PeDRA Research Grants, Career Bridge Research Grant, Pediatric Alopecia Areata Challenge Grant, and Childhood Eczema Challenge Grant programs. Research Grants are given to support early-stage research projects to lay the foundation for larger-scale studies in the future, while the Career Bridge Research Grant is intended to support one mid-career investigator in the conduct of an innovative research study in the field of pediatric dermatology. Run in partnership with the National Alopecia Areata Foundation (NAAF), the Pediatric Alopecia Areata Challenge Grant supports research investigations focused on pediatric alopecia areata. The Childhood Eczema Challenge Grant, supported in partnership with the National Eczema Association (NEA), is intended for early or mid-career scientists to accelerate research that improves the health and quality of life of pediatric eczema patients and their families.

        Click through the links below to learn more about each of these grant recipients and their funded projects.

        2022 PeDRA Research Grants

        Yakir Levin, MD, PhD of Massachusetts General Hospital, will conduct a project titled “Pilot study of novel therapy for the treatment of disfiguring congenital melanocytic nevi.”

        Hazel Wilkie, PhD of Boston Children’s Hospital, will conduct a project titled “T regulatory cell dysfunction and Staphylococcus aureus infection enable atopic dermatitis onset and progression.“

        2022 Career Bridge Research Grant

        Dawn Siegel, MD of Stanford University, will conduct a project titled “Biomarkers of Neurovascular Complications in PHACE Syndrome.”

        2022 Pediatric Alopecia Areata Challenge Grant – Supported in partnership with NAAF

        Chantal Cotter, MD of St. John’s Institute of Dermatology, will conduct a project titled “Alopecia & Us: studying the impact of alopecia areata to adolescents and the family.”

        2022 Childhood Eczema Challenge Grant – Supported in partnership with NEA

        Emily Croce, PhD, MSN, ADPRN, NPNP-CP of the University of Texas at Austin, will conduct a project titled “Childhood Atopic Dermatitis: The Role of Outdoor Air Pollution on Disease Burden and Racial and Ethnic Disparities.”


        We are currently accepting applications for the Emerging Investigator Research Grants and Research Fellowships programs. To learn more about PeDRA’s funding opportunities, visit PeDRA’s Grants & Fellowships Page.

        Interested in supporting research projects focused on childhood skin diseases through the PeDRA Grants and Fellowships Program? Click here to donate now or email us to discuss named grants opportunities.

        Special thanks to the SPD Foundation for their support of 2022 Research Grants.


        Filed Under: News

        Imposter No More

        January 23, 2023 By Jenn Dawson

        Click here to watch

        Filed Under: Uncategorized

        Grants & Fellowships Guidelines

        January 19, 2023 By Caitlin Haskell

        View PeDRA’s Grants & Awards Guidelines below, or view as a PDF here.

        1. How to Submit: Unless directed otherwise, applicants must submit applications through the online portal specified in the corresponding request for applications (RFA) by the date specified. Applicants are encouraged to create an account and review the online application before preparing materials.
        2. Application Requirements: Specific requirements for each funding opportunity will be included in the corresponding RFA. Applicants should carefully review the RFA and prepare all materials before beginning the online application.
        3. Format Requirements: All written materials (e.g., research proposal, budget, and biosketches) must be prepared in single-spaced Arial 11-point font or comparable standard font that is no smaller than Arial 11. Pages must be 8.5” x 11” in size with no less than one-half inch margins on all sides. Font contained in tables, figures, and letters of support may deviate from these guidelines if it is legible.
        4. Individual vs. Collaborative Studies: Unless specifically noted otherwise in an RFA, funding applications may be submitted by either a single principal investigator or collaboratively by a principal investigator with co-investigators (or co-principal investigators) from the same or different institutions. Biosketches from the principal investigator and all co-investigators must be included with application materials and the budget should reflect how funds will be used across multiple institutions when applicable. While not required, principal investigators are strongly encouraged to include letters of support from all co-investigators.
        5. Layman’s Summary vs. Abstract: Both a layman’s summary and abstract are required with every submitted application. The layman’s summary (150-word maximum) should clearly summarize the hypothesis, methods, and significance of the proposed research for the layperson audience using simple language. The abstract (250-word maximum) should summarize the hypothesis, methods, and significance of the proposed research for the scientific audience and may include scientific jargon and preliminary data. Please note that the layman’s summary from successful applications may be shared publicly on the PeDRA website or other channels of communication.
        6. Cover Letter: A cover letter must be provided with every application. The letter should appear on institutional letterhead and be addressed to the PeDRA Grants Committee. The letter should provide context for the accompanying application materials and describe how the proposal satisfies the goals of the corresponding RFA. In cases of resubmission or overlapping funds, the cover letter must address these items directly as described below (see “Resubmission” and “Overlapping Funds”). The cover letter should not be used to exceed the page limit of any other component of an application.
        7. Budget: Unless specifically noted otherwise in an RFA, budgets should be prepared using the NIH budget template, available here: https://grants.nih.gov/grants/funding/phs398/fp4.pdf. Budgets may include travel support and salary support for principal investigator(s), co-investigator(s), and research staff. PeDRA may award projects based on the original budget or make conditional awards dependent upon requested adjustments to the original budget. Funds may only be used for the work proposed according to the original budget. Any significant deviation from the original budget must be approved by PeDRA. Please send any such requests to research@pedraresearch.org along with a written justification.
        8. Proposal: Proposals should provide a concise description of the project to be conducted that addresses specific requirements described in the corresponding RFA. Applicants are encouraged to carefully organize their proposals for logic and readability. Tables and figures may be embedded within the text and should be referenced in the proposal’s narrative.
        9. Biosketches: Biosketches must be provided from the principal investigator and all co-investigators, or in the case of Research Fellowships the mentor and fellow. Biosketches must adhere to the 5-page NIH format, available here: https://grants.nih.gov/grants/forms/biosketch.htm.
        10. Award Period: Projects are expected to begin within six-months of the application due date. Special requests to extend this time-period must be submitted in writing to research@pedraresearch.org and will be evaluated on a case-by- case basis. Applicants should carefully consider this requirement when deciding which cycle is most appropriate for their submission.
        11. Award Disbursement: Upon receipt of a fully executed grant agreement, PeDRA will either (a) disburse the full amount of the grant as a single check or electronic fund transfer to the institution of the principal investigator or fellowship mentor or (b) disburse fractions of the award amount over a prespecified schedule that may be dependent upon interim milestones being met. It is the responsibility of the awardee to provide complete and accurate payee information after receiving award notification to ensure timely payment. It is the responsibility of the Principal Investigator and host institution to coordinate the distribution of funds to co-investigators at other institutions.
        12. IRB and IACUC Approval: All research involving human subjects or animals must have proper regulatory approval before any work takes place. Applicants must attest to IRB/IACUC approval status in the online application, and awardees must agree to provide a copy of IRB/IACUC as a condition of funding. Proof of ongoing approval is necessary on a yearly basis. While not required, applicants are strongly encouraged to obtain IRB approval before applying to begin research within the required six-month window (see “Award Period” above).
        13. Transfers: Requests to transfer investigator(s) or institution(s) during an award period will be evaluated on a case-by-case basis. Principal investigators must submit such requests in writing to research@pedraresearch.org no fewer than six weeks prior to the proposed move. PeDRA may approve such transfers or terminate the award and request for the remaining award balance be returned.
        14. Departmental and Indirect Costs: Award funds are to be used only for the designated recipient and project for which the application was submitted. Award funds cannot be used for indirect costs of the institution or departmental costs.
        15. Publications and Presentations: Public dissemination of the funded research (e.g., publications, abstracts, posters, presentations) must acknowledge support from “Pediatric Dermatology Research Alliance (PeDRA)”. In the case of posters and presentations, the PeDRA logo should be included. PeDRA should be notified of any such published work at least two weeks before public dissemination, and a copy of any such public dissemination should be forwarded to research@pedraresearch.org. Award recipients are asked to submit their work for presentation at the PeDRA Annual Conference(s) during and after their award periods.
        16. Multiple Submissions: Individuals may not serve as principal investigator or fellowship mentor on more than one application to the same funding program in the same cycle. However, the following scenarios are allowed:
          • Multiple applications may be submitted from different individuals at the same institution in the same cycle.
          • Individuals may serve in different capacities on multiple applications in the same cycle (e.g., co-investigator or collaborator).
          • Individuals may serve as principal investigator or fellowship mentor on multiple applications in the same calendar year.
          • Individuals may serve as principal investigator or fellowship mentor on an application while serving as principal investigator or fellowship mentor on another active PeDRA grant or award.
          • In such cases when funds from two PeDRA funding programs may overlap, care should be taken to justify the use of all funds in budgets and cover letters (see “Overlapping Funds” below).
        17. Resubmissions: PeDRA strongly encourages the resubmission of unfunded applications in subsequent grant cycles. In such cases, applicants should address reviewer feedback and demonstrate meaningful changes to their application. The cover letter should be used to address reviewer comments and describe the changes that were made.
        18. Eligibility: Unless specifically noted otherwise in an RFA, investigators or mentors on fellowship grants need not be trained in pediatric dermatology but must hold the degree of MD and/or PhD (or equivalent) and be eligible to apply for grants under the guidelines of their host institution.
        19. Overlapping Funds: Principal investigator(s) and/or co-investigator(s) may have, or be in concurrent pursuit of, funding from another source for the same, or a similar, project. If this is the case, the budget justification and cover letter must provide an adequate explanation of how funds from the multiple sources will be used.
        20. Reporting: Within six weeks of an award’s termination date, awardees must submit a final written report. If reports are not received within this six-week period, awardees will be ineligible to apply as principal investigator or fellowship mentor on subsequent PeDRA grants or fellowships until final reports are received. Final reports must include two components:
          • A Project Report must describe activities undertaken during the award period, data gathered and their interpretation, any obstacles encountered, and any deviations from the original proposal. The project report must also list all public dissemination of the research, including content that is in preparation, submitted, or under review.
          • A Financial Report must provide a detailed accounting of how funds were used. This is often prepared by a university’s grants office and may be sent directly to PeDRA separate from the project report. Any remaining balance at the end of the award must be returned to PeDRA immediately.
        21. No Cost Extensions: Awardees may request no cost extensions of up to eighteen months should a balance remain at the end of the award period. No cost extension requests will be evaluated on a case-by-case basis and must be submitted no fewer than one month prior to the end of the award period as a written request with brief justification to research@pedraresearch.org.
        22. Renewals: In some cases, grantees may apply for additional year(s) of funding through a competitive renewal process.
          • Eligibility: Such opportunities will be communicated in RFAs for specific funding mechanisms in specific years. Only grantees for these application cycles will be eligible (e.g., a 2019 grantee would not become eligible for renewal in 2020 if the opportunity is offered for the first time in 2020).
          • Procedure: To request a renewal, active grantees must submit a written request by email to research@pedraresearch.org no later than one month before the award end date. Requests must include the following:
          • Cover letter (2-page maximum)
          • Progress report (2-page maximum) – will satisfy the project report requirement for the original award term
          • Project proposal (3-page maximum, not including references)
          • Budget (2-page maximum) – Provide a detailed budget and brief justification that includes an explanation of any actual or anticipated overlapping funds and plans for support beyond the award period (if applicable)
          • Biosketches (5-page maximum per biosketch) – only required if new personnel are joining the study team
            Renewal requests will be reviewed by the PeDRA Grants Committee and applicants will be notified of the outcome no later than the original award end date.

        Filed Under: Uncategorized

        Alopecia & Us: studying the impact of alopecia areata to adolescents and the family

        January 17, 2023 By Katherine Devenport


        Principal Investigator:

        Chantal Cotter, MD
        St. John’s Institute of Dermatology

        Overview:

        Alopecia areata (AA) is one of the most common hair loss disorders characterized by loss of hair in round patches, usually on the scalp. The exact cause of AA is unknown, but it seems to be caused by the immune system attacking the hair follicles by mistake. Having AA can have impact on a child’s sense of well-being and increase their risk of mental health disorders including depression, anxiety, and OCD. Further, there may an impact on the family’s quality of life. Understanding this burden is paramount to ensuring we understand the full effect AA has on a child. We will do this via an online questionnaire which patients (aged 12-18) and their families can complete at home, anytime, anywhere in the world and in any language. Only through awareness of the full impact of this disease we will be able to advocate for access to treatments but also campaign for recognition and support of mental health in this group.

        Status:

        This project was funded by a 2022 Pediatric Alopecia Areata Challenge Grant.

        Filed Under: Hair Disorders

        Research Fellowships Program – ACCEPTING APPLICATIONS

        January 17, 2023 By Katherine Devenport

        Overview
        Childhood skin diseases are associated with severe burden on patients, families, and health care providers. Despite this burden, effective treatments remain sparse and the pace of research slow. To help overcome these challenges, the PeDRA Research Fellowship program supports one year of mentored research for post-graduate trainees and medical students in the field of pediatric dermatology.


        Goals
        The Research Fellowships program is driven by PeDRA’s mission to create, inspire, and sustain research to prevent, treat, and cure childhood skin disease. Fellowships are intended to support the development of the next generation of physician scientists and the advancement of active research projects in the field of pediatric dermatology.

        Important Details

        • Up to $20,000 to support a one-year fellowship stipend for a trainee or medical student conducting a project relevant to pediatric dermatology.
        • Research Fellowship terms to take place at the institution of the fellowship mentor.
        • Fellowship mentors must be Active Members of PeDRA.
        • As many as eight fellowships anticipated in 2023.
        • Application deadline of Thursday, March 30, 2023.
        view the rfa
        application portal

        2022 Research Fellowship Recipients:

        Siri Choragudi & Gil Yosipovitch, MD

        Research Fellowship Award

        University of Miami Miller School of Medicine

        Effects of IBAT inhibitors on itch in pediatric liver disease patients

        Read More…

        Jaron Nazaroff & Jean Tang, MD, PhD

        Research Fellowship Award

        Stanford University

        Online, Home-Based Epidermolysis Bullosa Patient Registry

        Read More…

        Roseline Okonkwo, MD & Michele Ramien, MD, MSc, FRCPC

        Research Fellowship Award

        Alberta Children’s Hospital

        Consensus Management of RIME in Children and Adolescents

        Read More…

        Yaron Noam Zafrir & Elena Pope, MD

        Research Fellowship Award

        SickKids Hospital – Toronto, Canada

        Hypopigmented mycosis fungoides True lymphoma or T-cell dyscrasia: A Retrospective and prospective cohort study

        Read More…

        Austin Johnson & Joyce Teng, MD, PhD

        Research Fellowship Award

        Stanford School of Medicine

        Epidermolysis Bullosa Simplex Disease Activity and Response Tool (EBSdart): Scoring Clinical Severity and Outcomes in Epidermolysis Bullosa Simplex

        Read More…

        Micah Pascual & Lucinda Kohn, MD, MHS

        Research Fellowship Award

        University of Colorado School of Medicine

        Daxpe: Native Skin Health Survey

        Read More…

        Jennifer Sui & Dawn Eichenfield, MD, PhD

        Research Fellowship Award

        UC San Diego School of Medicine

        Characterization of non-coding genetic loci and transcription factors that drive development of linear morphea

        Read More…

        Diana Zarowin & James Treat, MD

        Research Fellowship Award

        Children’s Hospital of Philadelphia

        N-Acetylcysteine for Habit – Based Cutaneous Conditions: A Review of Real-World Use in the Pediatric Population

        Read More…

        Special thanks to AbbVie, Incyte, Pfizer, Sanofi Genzyme and Regeneron Pharmaceuticals, and individual donors for their support of 2022 PeDRA Research Fellowships.

        Past Research Fellowships

        Filed Under: Career Support and Training, Early Stage Ideas and Investigators, Funding Opportunities

        A Welcome Message from PeDRA’s New President

        January 12, 2023 By Caitlin Haskell

        January 12, 2023 – (Email sent to PeDRA members from PeDRA’s President, Anna Bruckner, MD)

        Dear PeDRA Members:

        I hope you and your family had a wonderful holiday season and your New Year is off to a great start. I am thrilled to serve as your PeDRA President for the 2022-2024 term. With this email, I wanted to share an update on where we are, some things to look forward to in 2023, a little bit about my vision for where PeDRA will be by the time I end my term in 2024, and a few simple calls to action.

        2023 is PeDRA’s eleventh year as an organization. As we look ahead at the coming year and the start of my term, I’d like to first celebrate what PeDRA has accomplished in its first 10 years. Our membership has grown to over 700 members, we’ve published 70 peer-reviewed papers, have more than 100 active studies, and since 2016, we’ve awarded more than $1.3 million in funding to support pediatric dermatology research. Beyond the numbers, PeDRA has undeniably built from the simple idea to accelerate research through collaboration to become a hub of research infrastructure and a beacon of hope for patients, families, and clinicians to ease the burden of pediatric skin diseases and conditions.

        One of PeDRA’s greatest assets has always been its ability to grow and change quickly and in sync with the ever-evolving field of pediatric dermatology. We aren’t rooted in the way things were, we don’t assume that what worked one year will also work the next, and we are always ready to tackle the next big obstacle or pursue the next opportunity. In the coming year, you will see a number of programs that reflect these qualities. The new Emerging Investigator Research Grants Program will add to PeDRA’s already impressive lineup of grants and fellowship offerings with a program dedicated to supporting short-term research projects for a broad and diverse group of students and pediatric residents. The Industry 101 podcast series will explore relevant skills, opportunities, and considerations for productive partnerships with industry which are so important for the research we do to ultimately yield discoveries that reach the patient bedside as meaningful treatment and disease management options. And thanks to the adaptive nature of our Focused Study Group structure, nobody knows what new collaborative research groups we’ll see in place by this time next year. But I’m confident our network will adapt to fill any new research gaps that emerge.   

        Looking further ahead, here are three things I look forward to during my term as president:

        1. PeDRA will see you, our members, make us proud. You will flourish and thrive as leaders at your respective career stages because of the community, skills, and support you receive from PeDRA. Medical students will become dermatology residents, then pediatric dermatology fellows, and broaden our work force; early investigators will establish themselves as clinician-scientists, leading their own studies; and our mid-career and established investigators will solidify their standing as leaders in the field. PeDRA has been investing heavily in its mentorship and fellowship programs in recent years, with 20 research fellows and 200 mentees flowing through since 2019. I am so excited to see the impact these individuals will have on the field.

        2. PeDRA will cultivate and deepen its relationships with basic and translational scientists and clinician-scientists from other disciplines. So many “non-traditional” pediatric dermatology investigators have perspectives that can enrich our community, research skills and experiences that many pediatric dermatologists lack, and insights into novel biology, epidemiology, and technology that will make our network stronger.

        3. PeDRA will continue to offer a robust and dynamic lineup of easily accessible resources, grants, fellowships, and education programs, including our fantastic Annual Conference. Consider these tools your multipliers – the wind in your sails that will help you generate new knowledge that heals children with skin disease.

        Please help us realize this future together by taking just a few minutes to complete the current PeDRA Members Survey and update your PeDRA member profile. These simple tools help us stay abreast of the interests, priorities, and capacities of our members and allow us to build programs that are most relevant to the greatest number of people. It’s also how we gather member interest in joining a committee or one of our Focused Study Groups.

        Thank you for allowing me to serve as your PeDRA President. I hope to see you at the 11th PeDRA Annual Conference this November in Atlanta and, until then, please do not hesitate to contact me with any questions or ideas.

        Best wishes for the New Year,


        Stay tuned – Dr. Bruckner will be our first guest on Episode 1 of Getting to Know You Season 3 which will be released later this month.
         
        If you haven’t done so already, please renew your membership and continue to connect and collaborate with our vibrant network and enjoy member-exclusive resources. Not a member yet? Join today!

        Filed Under: News

        Biomarkers of Neurovascular Complications in PHACE Syndrome

        January 12, 2023 By Katherine Devenport


        Principal Investigator:

        Dawn Siegel, MD
        Stanford University School of Medicine

        Overview:

        Large infantile hemangiomas on the face, can be associated with developmental anomalies of the brain, blood vessels, heart, and eyes. The goal of our study is to understand if there are patterns on brain imaging studies and genetic tests that correlate with risk of neurovascular complications in PHACE. The knowledge gained in this study will be used to understand which individuals with PHACE are at greatest risk for progressive blood vessel changes in the brain and determine who is at risk for stroke. This information will be used to design future studies to prevent and treat the blood vessel changes before complications occur.

        Status:

        This project was funded by a 2022 Career Bridge Research Grant.

        Filed Under: Birthmark Studies

        T regulatory cell dysfunction and Staphylococcus aureus infection enable atopic dermatitis onset and progression

        January 12, 2023 By Katherine Devenport

        Principal Investigator:

        Hazel Wilkie, PhD
        Boston Children’s Hospital

        Overview:

        Atopic dermatitis (AD, also called allergic eczema) affects 20% of children and 10% of adults. The dry, red, itchy skin lesions are often infected with bacteria. Intriguingly, skin bacterial burden increases prior to the development of eczema lesions in infant children but how or if the bacteria is causing the disease is not clear.

        AD often occurs in children whose parents also suffer from allergies. This heritable link is associated with mutations in numerous genes. Patients with mutations in the DOCK8 gene universally suffer from severe AD and bacterial infections. Mice with the same DOCK8 mutations as the patients are an excellent model to investigate the pathways underlying the development of AD. We will test novel treatment strategies that target these pathways in order to reduce allergic skin inflammation.

        This work will illuminate novel therapies for eczema patients targeted towards preventing disease and restoring suppression of allergic skin inflammation.

        Status:

        This project was funded by a 2022 PeDRA Research Grant.

        Filed Under: Active Studies, AD&PsO Ongoing, Atopic Derm & Psoriasis

        • Go to page 1
        • Go to page 2
        • Go to page 3
        • Interim pages omitted …
        • Go to page 35
        • Go to Next Page »

        Footer

        • Our Membership
        • For Patients
        • For Researchers
        • Governance Policies
        • Financial Conflict of Interest Policy
        • Jobs at PeDRA
        • Facebook
        • Instagram
        • LinkedIn
        • Twitter
        • YouTube
        Sign up to receive emails from PeDRA
        Join PeDRA
        Donate

        Copyright © 2023 · Pediatric Dermatology Research Alliance (PeDRA) · All Rights Reserved. · Privacy Policy